LDT
ADAMTS13, Angiopoietin-2, BMP-9, D-Dimer, Endoglin, Endothelin-1, FGF-1, Follistatin, HB-EGF, HGF, Leptin, PLGF, SAA, sICAM-1, sP-Selectin, sVCAM-1, VEGF-C, VEGF-D
LCOV18
Available upon request
Reference intervals available for PLASMA-EDTA samples
Available upon request
Utilize our advanced Long COVID Vascular Health 18-Plex Panel to investigate dysfunctions in vascular and endothelial integrity, coagulation, and inflammation. This panel is designed to assess circulating factors that may reveal abnormalities in angiogenesis, coagulation, vascular function, and inflammatory responses—critical elements believed to play a role in the pathogenesis of long COVID.
Our specialized panel offers a thorough approach to exploring vascular and endothelial dysfunction, coagulation, and inflammation, providing valuable insights into the pathogenesis of long COVID. This panel facilitates examination of persistent vascular injury and related abnormalities that are essential for understanding the long-term effects of COVID-19.
Moreover, the Long COVID Vascular Health 18-Plex Panel is crucial for studying cardiovascular diseases such as myocardial infarction and stroke. It includes important markers like sP-Selectin, which indicates endothelial activation, and D-Dimer, a marker for clot formation and breakdown. Additionally, it is well-suited for analyzing the complex interactions of growth factors and cytokines involved in vascular development, tissue repair, and conditions like cancer and cardiovascular disorders. Evaluating these biomarkers offers deeper insights into angiogenesis, inflammation, and cell proliferation.
Many biomarkers in the Long COVID Vascular Health 18-Plex Panel are specifically associated with coagulation, making serum an unsuitable sample type for this assay. The panel is recommended for plasma samples only, preferably EDTA.
Leverage this panel to gain a deeper understanding and drive impactful diagnostics and targeted therapeutics in long COVID.